Overview of services:
|Steve Hetey, MS, RPh, FASHP, Associate Chief Pharmacy Officer|
The Department of Pharmacy, Women’s and Children’s Hospital (240 beds) provides clinical and distributive services which support care of pediatric patients, obstetrics-gynecology and 10 adult internal medicine patients in the inpatient setting. Distributive services are supported on the inpatient side by the 5th floor pediatric satellite pharmacy. The McGovern-Davison Children’s Health Center ambulatory pediatric pharmacy services are supported by an infusion center pharmacy located on the 4th floor of the health center.
- Inpatient pharmacy services: Practice models within the pediatrics division are both integrated as well as specialized. Clinical pharmacists participate in daily patient care rounds to develop individual pharmacotherapy plans, provide medication and dosage recommendations/adjustments, pharmacokinetic evaluation and dosing, parenteral nutrition management, code blue and rapid response participation, education, research and publication. Specialized practice areas include pediatric bone marrow transplant (16 beds), pediatric intensive care (16 beds), pediatric cardiac intensive care (13 beds), and neonatal intensive care (60 beds) units. General pediatric pharmacists round daily on 3 general pediatric services, infectious diseases, hematology-oncology, cardiology, neurology, gastroenterology, solid organ transplant and allergy/immunology. The 5th floor pediatric satellite pharmacy supports the medication needs of these patient populations in collaboration with the Inpatient Operations Division.
- Ambulatory pharmacy services: The Children’s Health Center Pharmacy is a sterile compounding facility located on the 4th floor of the Children’s Health Center building. Both low and medium risk doses of hazardous and non-hazardous compounded sterile preparations are provided to ambulatory pediatric patients. Clinical pharmacists, in collaboration with providers, monitor appropriateness of drug, dosage, frequency and adherence to protocols. Additionally, clinical pharmacists and technicians support investigational drug use.